Read + Share
Amedeo Smart
Independent Medical Education
Maurer M, Gimenez-Arnau A, Bernstein JA, Chu CY, et al. Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study. Allergy 2022;77:2175-2184.PMID: 34773261
Email
LinkedIn
Facebook
Twitter
Privacy Policy